Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients.

AIDS and behavior - 1 Jan 2013

Lo Re Vincent, Teal Valerie, Localio A Russell, Amorosa Valerianna K, Kaplan David E, Gross Robert

Abstract excerpt

Adherence to hepatitis C virus (HCV) therapy has been incompletely examined among HIV-infected patients. We assessed changes in interferon and ribavirin adherence and evaluated the relationship between adherence and early (EVR) and sustained virologic response (SVR). We performed a cohort study among 333 HIV/HCV-coinfected patients who received pegylated interferon and ribavirin between 2001 and 2006 and had HCV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to CD4 Lymphocyte Count
Share to Coinfection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis C

Share to Interferons

Share to Ribavirin

Share to Socioeconomic Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 22907288
DOI: 10.1007/s10461-012-0288-9
PMCID: PMC3514597

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients.PMID 22907288Read ↗

Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study.Semantic proximity Read ↗

Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response.Semantic proximity Read ↗

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.Semantic proximity Read ↗

Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES.Semantic proximity Read ↗

Impact of ribavirin exposure on early virological response to hepatitis C therapy in HIV-infected patients with chronic hepatitis C.Semantic proximity Read ↗

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens.Semantic proximity Read ↗

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.Semantic proximity Read ↗

Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection.Semantic proximity Read ↗

Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients.Semantic proximity Read ↗

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.Semantic proximity Read ↗

Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection.Semantic proximity Read ↗

Long-term virological and adherence outcomes to antiviral treatment in a 4-year cohort chronic HBV study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.